Can PrEP work for people who use drugs? new study aims to find out
NCT ID NCT07385183
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how to help people who use drugs start and keep taking PrEP, a daily pill that prevents HIV. Researchers will follow 200 participants from the emergency department for one year, tracking who stays on the medication and what helps or hinders them. They will also interview doctors and peer workers to understand barriers. The goal is not to test if PrEP works—that's already proven—but to find real-world solutions for this high-risk group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Descovy (F/TAF)
- What this could lead to
- If successful, this could show practical ways to improve HIV prevention in a high-risk group that often struggles with access and adherence.
- What could go wrong
- This is an observational study, not a test of the drug's effectiveness. It may not lead to changes in care if barriers are too complex or if adherence remains low.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PEOPLE WHO INJECT DRUGS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- STI tests boost HIV prevention in pregnant women
- Can a phone app help end HIV stigma and boost prevention?
- App and home delivery aim to keep youth HIV-free
- Hidden crisis: drug users face high rates of partner violence
- New behavioral program aims to curb HIV and drug use in High-Risk men
- Hand gel study for injection abscesses pulled before it started